Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortTargeted antibody for HER2-positive breast cancer.Hormone therapy that has saved hundreds of thousands from breast cancer.
Body systemCancerCancer
Drug classTargeted antibodiesSelective oestrogen receptor modulators
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesHER2-positive breast cancer (early and advanced), HER2-positive stomach cancerHormone-receptor-positive breast cancer (pre- and post-menopause), Breast cancer prevention in high risk, Male breast cancer
How it worksLocks onto a growth signal on some breast cancer cells and flags them for destruction.Stops oestrogen fuelling breast cancer cells.
Starts working——
Half-lifeAbout 28 days5–7 days
Typical adult doseIV loading then every 3 weeks for a year (early breast cancer), or 600 mg subcutaneously every 3 weeks.20 mg once a day for 5–10 years.
FormsIV infusion, Subcutaneous injectionTablet, Oral solution
Common side effectsInfusion reactions, Diarrhoea, TirednessHot flushes, Vaginal discharge, Irregular periods, Mood changes
Serious side effectsHeart muscle weakness, Lung problems (rare)Blood clots, Womb cancer (post-menopause), Stroke, Cataracts
Don't take if—Pregnancy; History of blood clots (caution); Taking potent CYP2D6 inhibitors (paroxetine, fluoxetine) — reduces effect; Undiagnosed vaginal bleeding
Alcohol—Usually no problem in moderation. No specific interaction.
PregnancyUsually avoidedCan reduce amniotic fluid; contraception for 7 months after.Usually avoidedCan harm the fetus; avoid pregnancy for 2 months after stopping.
Breastfeeding—Usually avoidedAvoid.
In use since19981973
Brand namesUnited States: Herceptin, Ogivri, KanjintiUnited Kingdom: Herceptin, Herzuma, OntruzantIndia: CANMAb, Hertraz, VivitraUnited States: SoltamoxUnited Kingdom: Nolvadex-D, SoltamoxIndia: Tamodex, Mamofen
Legal status—United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeL01FD01L02BA01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker